PDB Short entry for 3QKM HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-FEB-11 3QKM TITLE SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: PROTEIN KINASE B, PKB, PROTO-ONCOGENE C-AKT, RAC-PK-ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.XU,A.BANKA,J.F.BLAKE,I.S.MITCHELL,E.M.WALLACE,S.L.GLOOR, AUTHOR 2 M.MARTINSON,T.RISOM,S.D.GROSS,T.MORALES,G.P.A.VIGERS,B.J.BRANDHUBER, AUTHOR 3 N.J.SKELTON REVDAT 2 20-APR-11 3QKM 1 JRNL REVDAT 1 06-APR-11 3QKM 0 JRNL AUTH R.XU,A.BANKA,J.F.BLAKE,I.S.MITCHELL,E.M.WALLACE,J.R.BENCSIK, JRNL AUTH 2 N.C.KALLAN,K.L.SPENCER,S.L.GLOOR,M.MARTINSON,T.RISOM, JRNL AUTH 3 S.D.GROSS,T.H.MORALES,W.I.WU,G.P.VIGERS,B.J.BRANDHUBER, JRNL AUTH 4 N.J.SKELTON JRNL TITL DISCOVERY OF SPIROCYCLIC SULFONAMIDES AS POTENT AKT JRNL TITL 2 INHIBITORS WITH EXQUISITE SELECTIVITY AGAINST PKA. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2335 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21420856 JRNL DOI 10.1016/J.BMCL.2011.02.098 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 18627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 947 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1124 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2696 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 308 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.11000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : -2.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.228 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.608 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2805 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3781 ; 1.040 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 328 ; 5.498 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 135 ;33.286 ;23.556 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 503 ;13.739 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;19.283 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 392 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2125 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1640 ; 0.419 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2643 ; 0.808 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1165 ; 1.098 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1138 ; 1.911 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QKM COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-11. REMARK 100 THE RCSB ID CODE IS RCSB063763. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19600 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : 0.14000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : 0.34000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9.7MG/ML PROTEIN, 0.6MM GSK-3 BETA REMARK 280 PEPTIDE, 1MM MG-AMPPNP, 10MM DTT, 22% PEG 4K, 10% ISOPROPANOL, REMARK 280 0.1M HEPES, PH 7.8, UNDER OIL, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.52150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.99050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.96900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.99050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.52150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.96900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 140 REMARK 465 ALA A 141 REMARK 465 MET A 142 REMARK 465 ALA A 143 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 THR A 479 REMARK 465 ALA A 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 153 -61.40 -97.58 REMARK 500 THR A 219 -167.50 -105.24 REMARK 500 ARG A 243 -53.03 73.11 REMARK 500 ARG A 273 -16.64 71.02 REMARK 500 ASP A 292 92.07 70.66 REMARK 500 ASP A 302 -114.88 51.91 REMARK 500 ASP A 325 146.19 87.46 REMARK 500 ASP A 398 -124.19 52.21 REMARK 500 GLN A 428 45.17 -90.55 REMARK 500 THR A 450 -65.49 -137.54 REMARK 500 PHE A 472 56.47 -99.73 REMARK 500 ASP A 473 28.35 -140.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 548 DISTANCE = 5.61 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SM9 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OCB RELATED DB: PDB DBREF 3QKM A 144 480 UNP P31749 AKT1_HUMAN 144 480 SEQADV 3QKM GLY A 140 UNP P31749 EXPRESSION TAG SEQADV 3QKM ALA A 141 UNP P31749 EXPRESSION TAG SEQADV 3QKM MET A 142 UNP P31749 EXPRESSION TAG SEQADV 3QKM ALA A 143 UNP P31749 EXPRESSION TAG SEQADV 3QKM ASP A 473 UNP P31749 SER 473 ENGINEERED MUTATION SEQADV 3QKM SER A 478 UNP P31749 GLY 478 CONFLICT SEQRES 1 A 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 A 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 A 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 A 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 A 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 A 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 A 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 A 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 A 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 A 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 A 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 A 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 A 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 A 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 A 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 A 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 A 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 A 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 A 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 A 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 A 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 A 341 SER THR ALA MODRES 3QKM TPO A 308 THR PHOSPHOTHREONINE HET TPO A 308 11 HET SM9 A 1 41 HETNAM TPO PHOSPHOTHREONINE HETNAM SM9 N-(2-ETHOXYETHYL)-N-{(2S)-2-HYDROXY-3-[(5R)-2- HETNAM 2 SM9 (QUINAZOLIN-4-YL)-2,7-DIAZASPIRO[4.5]DEC-7-YL]PROPYL}- HETNAM 3 SM9 2,6-DIMETHYLBENZENESULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 SM9 C31 H43 N5 O4 S FORMUL 3 HOH *308(H2 O) HELIX 1 1 THR A 146 ASN A 148 5 3 HELIX 2 2 LYS A 183 LYS A 189 1 7 HELIX 3 3 GLU A 191 SER A 205 1 15 HELIX 4 4 GLU A 234 ARG A 243 1 10 HELIX 5 5 SER A 246 ASN A 269 1 24 HELIX 6 6 LYS A 276 GLU A 278 5 3 HELIX 7 7 THR A 312 LEU A 316 5 5 HELIX 8 8 ALA A 317 ASP A 323 1 7 HELIX 9 9 ALA A 329 GLY A 345 1 17 HELIX 10 10 ASP A 353 GLU A 364 1 12 HELIX 11 11 GLY A 373 LEU A 384 1 12 HELIX 12 12 ASP A 398 GLN A 404 1 7 HELIX 13 13 HIS A 405 ALA A 409 5 5 HELIX 14 14 VAL A 412 GLU A 418 1 7 HELIX 15 15 ASP A 439 ALA A 444 1 6 SHEET 1 A 6 PHE A 150 GLY A 159 0 SHEET 2 A 6 GLY A 162 GLU A 169 -1 O GLY A 162 N GLY A 159 SHEET 3 A 6 TYR A 175 LYS A 182 -1 O ILE A 180 N LYS A 163 SHEET 4 A 6 ARG A 222 GLU A 228 -1 O LEU A 223 N LEU A 181 SHEET 5 A 6 LEU A 213 GLN A 218 -1 N LYS A 214 O VAL A 226 SHEET 6 A 6 ASP A 473 SER A 475 -1 O TYR A 474 N SER A 216 SHEET 1 B 2 LEU A 280 LEU A 282 0 SHEET 2 B 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 LINK C LYS A 307 N TPO A 308 1555 1555 1.33 LINK C TPO A 308 N PHE A 309 1555 1555 1.33 SITE 1 AC1 23 GLY A 157 LYS A 158 GLY A 159 THR A 160 SITE 2 AC1 23 PHE A 161 GLY A 162 LYS A 163 VAL A 164 SITE 3 AC1 23 ALA A 177 LYS A 179 GLU A 191 THR A 211 SITE 4 AC1 23 MET A 227 GLU A 228 TYR A 229 ALA A 230 SITE 5 AC1 23 GLU A 234 GLU A 278 MET A 281 ASP A 292 SITE 6 AC1 23 PHE A 438 HOH A 510 HOH A 629 CRYST1 47.043 57.938 149.981 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021257 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017260 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006668 0.00000